Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 15.98
(-0.62%)
CNY 15.98
(-0.62%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.68 Billion CNY | 10.57% |
| 2022 | 1.48 Billion CNY | 45.76% |
| 2021 | 1.02 Billion CNY | 63.28% |
| 2020 | 624.98 Million CNY | 13.29% |
| 2019 | 551.65 Million CNY | 39.06% |
| 2018 | 396.71 Million CNY | 98.43% |
| 2017 | 199.92 Million CNY | 52.11% |
| 2016 | 131.43 Million CNY | 27.15% |
| 2015 | 103.36 Million CNY | 8.16% |
| 2014 | 95.57 Million CNY | -9.59% |
| 2013 | 105.71 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 296.5 Million CNY | -46.61% |
| 2024 Q2 | 392.89 Million CNY | 32.51% |
| 2024 Q3 | 388.06 Million CNY | 0.27% |
| 2023 FY | 1.64 Billion CNY | 10.57% |
| 2023 Q2 | 441.17 Million CNY | 52.14% |
| 2023 Q1 | 289.97 Million CNY | -40.31% |
| 2023 Q3 | 384.25 Million CNY | -12.9% |
| 2023 Q4 | 555.33 Million CNY | 44.52% |
| 2022 Q2 | 356.64 Million CNY | 24.12% |
| 2022 Q3 | 357.65 Million CNY | 0.28% |
| 2022 FY | 1.48 Billion CNY | 45.76% |
| 2022 Q4 | 485.83 Million CNY | 35.84% |
| 2022 Q1 | 287.33 Million CNY | -13.13% |
| 2021 Q1 | 159.26 Million CNY | -20.95% |
| 2021 FY | 1.02 Billion CNY | 63.28% |
| 2021 Q4 | 330.77 Million CNY | 32.34% |
| 2021 Q3 | 249.94 Million CNY | -10.9% |
| 2021 Q2 | 280.51 Million CNY | 76.13% |
| 2020 Q3 | 176.05 Million CNY | 20.28% |
| 2020 Q2 | 146.37 Million CNY | 44.81% |
| 2020 FY | 624.98 Million CNY | 13.29% |
| 2020 Q1 | 101.07 Million CNY | -38.84% |
| 2020 Q4 | 201.47 Million CNY | 14.44% |
| 2019 Q2 | 141.75 Million CNY | 41.51% |
| 2019 FY | 551.65 Million CNY | 39.06% |
| 2019 Q1 | 100.17 Million CNY | -12.34% |
| 2019 Q3 | 144.45 Million CNY | 1.9% |
| 2019 Q4 | 165.27 Million CNY | 14.41% |
| 2018 Q1 | 79.38 Million CNY | -1.31% |
| 2018 FY | 396.71 Million CNY | 98.43% |
| 2018 Q4 | 114.28 Million CNY | 7.03% |
| 2018 Q3 | 106.77 Million CNY | 10.91% |
| 2018 Q2 | 96.27 Million CNY | 21.27% |
| 2017 Q4 | 80.43 Million CNY | 86.57% |
| 2017 FY | 199.92 Million CNY | 52.11% |
| 2017 Q3 | 43.11 Million CNY | -2.76% |
| 2017 Q2 | 44.34 Million CNY | 38.42% |
| 2017 Q1 | 32.03 Million CNY | -9.85% |
| 2016 Q4 | 35.53 Million CNY | 1.34% |
| 2016 Q3 | 35.06 Million CNY | 14.77% |
| 2016 Q2 | 30.55 Million CNY | 31.02% |
| 2016 Q1 | 23.31 Million CNY | -21.73% |
| 2016 FY | 131.43 Million CNY | 27.15% |
| 2015 Q1 | 20.53 Million CNY | -25.09% |
| 2015 Q4 | 29.79 Million CNY | 0.0% |
| 2015 FY | 103.36 Million CNY | 8.16% |
| 2015 Q3 | 29.79 Million CNY | 45.07% |
| 2015 Q2 | 20.53 Million CNY | 0.0% |
| 2014 Q3 | 28.33 Million CNY | 63.56% |
| 2014 Q1 | 17.32 Million CNY | 0.0% |
| 2014 FY | 95.57 Million CNY | -9.59% |
| 2014 Q2 | 17.32 Million CNY | 0.0% |
| 2014 Q4 | 27.41 Million CNY | -3.27% |
| 2013 FY | 105.71 Million CNY | 0.0% |